logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

AACR 2019—Mesothelin CAR T-cell therapy shows benefit in solid pleural tumors

Phase 1 study demonstrates no on-target, off-tumor, or therapy-related toxicities.